Abstract 4140896: Variations in BNP Levels (35-100 pg/mL) and Their Implications for Predicting Future Heart Failure in Pre-clinical Stages A/B: Novel Risk Stratification Methods from the CHART-2 Study
Hiroyuki Takahama(Tohoku University), Satoshi Yasuda(National Institute of Health Sciences), Satoshi Miyata, Kazuma Oyama(Tohoku University), Jun Takahashi(Kyoto University), Kotaro Nochioka(Tohoku University), Takashi Shiroto(Tohoku University), Kai Susukita(Tohoku University), Takumi Inoue(Tohoku University), Hideka Hayashi(Tohoku University), Hiroaki Shimokawa(Tohoku University)
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
|Circulation|2014|456